Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
about
From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersAssessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.FNA smears of pancreatic ductal adenocarcinoma are superior to formalin-fixed paraffin-embedded tissue as a source of DNA: Comparison of targeted KRAS amplification and genotyping in matched preresection and postresection samples.Susceptibility of ATM-deficient pancreatic cancer cells to radiation.How to prepare, handle, read, and improve EUS-FNA and fine-needle biopsy for solid pancreatic lesions: The pathologist's role.Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer.The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer.Exact association test for small size sequencing data.Differential networking meta-analysis of gastric cancer across Asian and American racial groups.Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the "precision medicine" of pancreatic cancer: A retrospective study.
P2860
Q37631655-EAA89EE0-4341-4416-9EBB-36BA51E35985Q47170689-01924E64-2225-4604-8809-6A96BE684476Q47662044-7894CEA0-5EE2-419B-9E28-198B452D6C6AQ48218378-4BC5F792-8CC7-45E6-9204-2EC46383D508Q49507757-BE66D1D1-4E72-4D9D-BEEF-06BD5F4B48AEQ49576059-37EC546D-344F-41C5-9696-AEDA072F3104Q50640303-DC4122B9-3C46-430B-8086-FB62685B7176Q52561810-E06E5F22-765E-47EC-8F1B-412186465D8EQ55428797-5DF531DD-E193-474F-BDF2-DA5153753835Q55429215-259F7C73-0B26-4C83-B9F5-2B8326B818BA
P2860
Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted next generation seque ...... for optimal therapy selection.
@en
Targeted next generation seque ...... for optimal therapy selection.
@nl
type
label
Targeted next generation seque ...... for optimal therapy selection.
@en
Targeted next generation seque ...... for optimal therapy selection.
@nl
prefLabel
Targeted next generation seque ...... for optimal therapy selection.
@en
Targeted next generation seque ...... for optimal therapy selection.
@nl
P2093
P2860
P356
P1433
P1476
Targeted next generation seque ...... for optimal therapy selection.
@en
P2093
Benjamin R Kipp
Douglas M Minot
Ferga C Gleeson
George Vasmatzis
Jesse S Voss
John C Cheville
Konstantinos N Lazaridis
Michael J Levy
Michael R Henry
Rondell P Graham
P2860
P304
54526-54536
P356
10.18632/ONCOTARGET.9440
P407
P577
2016-05-18T00:00:00Z